Treatment of colorectal cancer in Sub‐Saharan Africa: Results from a prospective Nigerian hospital registry

Autor: Oladapo Adedayo Kolawole, Akinwumi O. Olakanmi, Adebowale I. Ajayi, Olaofe Oo, Adeleye D. Omisore, Ademola Adeyeye, Kazeem O O Ibrahim, Kenneth Seier, Aba Katung, Murray F. Brennan, Olalekan Olasehinde, Avinash Sharma, Olukayode Arowolo, Olusegun I. Alatise, Adewale O. Adisa, T. Peter Kingham, Akinwunmi O. Komolafe, A. O. Adesiyun, O C Famurewa, O. L. Idris, Ayoola D. Ibikunle, Mithat Gonen, S. O. Agodirin, Jeremy Constable, SA Olatoke, Ayoola A. Egberongbe, M. O. Adejumobi
Rok vydání: 2019
Předmět:
Zdroj: J Surg Oncol
ISSN: 1096-9098
0022-4790
DOI: 10.1002/jso.25768
Popis: BACKGROUND: Colorectal cancer (CRC) is the third most common cancer worldwide. Mortality for CRC is improving in high income countries (HIC), but in low and middle income (LMIC) countries, rates of disease and death from disease are rising. In Sub-Saharan Africa, the ratio of CRC mortality to incidence is the highest in the world. This study investigated the nature of CRC treatment currently being offered and received in Nigeria. METHODS: Between April 2013 and October 2017, a prospective study of consecutively diagnosed cases of CRC was conducted. Patient demographics, clinical features, and treatment recommended and received was recorded for each case. Patients were followed during the study period every three months or until death. RESULTS: Three hundred patients were included in our analysis. Seventy-one percent of patients received a recommended surgical operation. Of those that didn’t undergo surgery as recommended, 37% cited cost as the main reason, 30% declined due to personal reasons, and
Databáze: OpenAIRE